Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure

Odonate Therapeutics, Inc. (ODT) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/24/2021 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 200,000 shares @ $1.5483, valued at $309.7k
Sold 200,000 shares @ $1.5684, valued at $313.7k
11/19/2021 4 Davis Aaron I. (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 170,000 shares @ $2.2334, valued at $379.7k
Sold 600,000 shares @ $2.1654, valued at $1.3M
Sold 250,000 shares @ $1.949, valued at $487.3k
Sold 30,000 shares @ $1.9165, valued at $57.5k
Sold 150,000 shares @ $1.8419, valued at $276.3k
11/19/2021 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 600,000 shares @ $2.1654, valued at $1.3M
Sold 250,000 shares @ $1.949, valued at $487.3k
Sold 150,000 shares @ $1.8419, valued at $276.3k
11/19/2021 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 468,849 shares @ $2.6583, valued at $1.2M
Sold 31,151 shares @ $1.9941, valued at $62.1k
Sold 500,000 shares @ $2.0161, valued at $1M
Sold 287,577 shares @ $2.1985, valued at $632.2k
Sold 212,423 shares @ $1.9708, valued at $418.6k
Sold 500,000 shares @ $1.8812, valued at $940.6k
Sold 381,842 shares @ $1.8925, valued at $722.6k
Sold 365,289 shares @ $1.9161, valued at $699.9k
11/18/2021 3 EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Odonate Therapeutics, Inc.
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 35 shares @ $16.99, valued at $594.7
Granted 35 options to buy @ $19.99, valued at $699.7
01/20/2021 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 94 shares @ $16.99, valued at $1.6k
Granted 94 options to buy @ $19.99, valued at $1.9k
01/05/2021 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 350 shares @ $16.32, valued at $5.7k
Granted 350 options to buy @ $19.2, valued at $6.7k
01/05/2021 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 169 shares @ $16.32, valued at $2.8k
Granted 169 options to buy @ $19.2, valued at $3.2k
12/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2020 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Bought 75,000 shares @ $16.9, valued at $1.3M
Bought 225,000 shares @ $17.1091, valued at $3.8M
Bought 100,000 shares @ $17.4638, valued at $1.7M
12/30/2020 4 Davis Aaron I. (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Bought 75,000 shares @ $16.9, valued at $1.3M
Bought 225,000 shares @ $17.1091, valued at $3.8M
Bought 100,000 shares @ $17.4638, valued at $1.7M
12/23/2020 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Bought 62,144 shares @ $14.5753, valued at $905.8k
Bought 37,856 shares @ $14.5754, valued at $551.8k
Bought 36,646 shares @ $15.1673, valued at $555.8k
Bought 63,354 shares @ $15.4282, valued at $977.4k
Bought 75,784 shares @ $15.708, valued at $1.2M
12/17/2020 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 43 shares @ $12.91, valued at $555.1
Granted 43 options to buy @ $15.19, valued at $653.2
12/17/2020 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 121 shares @ $12.91, valued at $1.6k
Granted 121 options to buy @ $15.19, valued at $1.8k
12/10/2020 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 22,639 options to buy @ $16.52, valued at $374k
12/10/2020 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 60,373 options to buy @ $16.52, valued at $997.4k
12/10/2020 4 Johnson Laura L. (Director) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $16.52, valued at $247.8k
12/10/2020 4 Rosen Robert (Director) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $16.52, valued at $247.8k
12/10/2020 4 Johnson Craig A (Director) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $16.52, valued at $247.8k
12/02/2020 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 45 shares @ $12.77, valued at $574.7
Granted 45 options to buy @ $15.02, valued at $675.9
12/02/2020 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 122 shares @ $12.77, valued at $1.6k
Granted 122 options to buy @ $15.02, valued at $1.8k
12/02/2020 4 Lemkey John G (COO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 12 shares @ $12.77, valued at $153.2
Granted 12 options to buy @ $15.02, valued at $180.2
11/17/2020 4 Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 46 shares @ $12.2, valued at $561.2
Granted 46 options to buy @ $14.35, valued at $660.1
11/17/2020 4 O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Granted 128 shares @ $12.2, valued at $1.6k
Granted 128 options to buy @ $14.35, valued at $1.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy